Nevertheless, the specific role of SCLY in the tumorigenesis and progression of cancers derived from NAFLD or NASH, particularly at the early stages of cancer development, remains undetermined. This evidence concerns the gene SCLY and metabolic dysfunction-associated steatohepatitis.